SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-19-005611
Filing Date
2019-09-30
Accepted
2019-09-30 16:37:27
Documents
89
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm 10-K 1028129
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION ipix_ex31.htm EX-3.1 24193
3 DESCRIPTION OF CLASS A COMMON STOCK ipix_ex41.htm EX-4.1 8327
4 SUBSIDIARIES ipix_ex211.htm EX-21.1 1375
5 CONSENT ipix_ex231.htm EX-23.1 1978
6 CONSENT ipix_ex232.htm EX-23.2 1169
7 CERTIFICATION ipix_ex311.htm EX-31.1 7813
8 CERTIFICATION ipix_ex312.htm EX-31.2 7744
9 CERTIFICATION ipix_ex321.htm EX-32.1 2926
10 CERTIFICATION ipix_ex322.htm EX-32.2 2976
  Complete submission text file 0001477932-19-005611.txt   5919037

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT ipix-20190630.xml EX-101.INS 877981
12 XBRL TAXONOMY EXTENSION SCHEMA ipix-20190630.xsd EX-101.SCH 95415
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20190630_lab.xml EX-101.LAB 511694
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20190630_cal.xml EX-101.CAL 29079
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20190630_pre.xml EX-101.PRE 518973
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20190630_def.xml EX-101.DEF 329476
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 191126441
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences